Intuitive Surgical, Inc. (NASDAQ:ISRG) has received a consensus recommendation of “Buy” from the twenty ratings firms that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $579.06.
Several research analysts recently weighed in on the company. Piper Jaffray Companies upgraded Intuitive Surgical to an “overweight” rating and set a $610.00 target price on the stock in a research note on Wednesday, May 22nd. BidaskClub downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Friday, May 24th. Citigroup dropped their target price on Intuitive Surgical from $684.00 to $611.00 and set a “buy” rating on the stock in a research note on Tuesday, April 23rd. Zacks Investment Research downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Wednesday, April 24th. Finally, BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a research note on Sunday, April 21st.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 22,636 shares of the business’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $501.48, for a total transaction of $11,351,501.28. Following the sale, the chief executive officer now owns 386,866 shares in the company, valued at approximately $194,005,561.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Salvatore Brogna sold 1,172 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $500.60, for a total value of $586,703.20. Following the sale, the chief operating officer now owns 5,933 shares in the company, valued at approximately $2,970,059.80. The disclosure for this sale can be found here. In the last quarter, insiders have sold 27,621 shares of company stock worth $13,828,454. Company insiders own 1.70% of the company’s stock.
Shares of ISRG stock opened at $533.05 on Tuesday. Intuitive Surgical has a 1-year low of $430.24 and a 1-year high of $589.32. The firm has a market cap of $60.26 billion, a P/E ratio of 56.17, a price-to-earnings-growth ratio of 4.55 and a beta of 1.06.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.70 by ($0.09). Intuitive Surgical had a return on equity of 17.33% and a net margin of 29.78%. The business had revenue of $974.00 million for the quarter, compared to analysts’ expectations of $975.27 million. During the same quarter last year, the firm earned $2.44 earnings per share. The firm’s quarterly revenue was up 14.9% compared to the same quarter last year. As a group, analysts predict that Intuitive Surgical will post 9.4 earnings per share for the current year.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: How to Track your Portfolio in Google Finance
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.